Preparation of high specific activity tritium‐labelled leukotriene B4 suitable for radioligand binding assay |
| |
Authors: | Stanislav I. Schramm Igor Yu. Nagaev Alan Sabirsh Valeriy P. Shevchenko Anastasiya S. Arkhipova Jesper Z. Haeggström Nikolay F. Myasoedov |
| |
Affiliation: | 1. Department of Chemistry of Physiologically Active Compounds, Institute of Molecular Genetics of the Russian Academy of Sciences, Kurchatov Sq. 2, Moscow 123182, Russia;2. Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S‐171 77 Stockholm, Sweden |
| |
Abstract: | We describe a method of preparation of high specific activity tritium‐labelled leukotriene (LT) B4 from [5,6,8,9,11,12,14,15‐3H] arachidonic acid (AA; 6.66 TBq/mmol) utilizing a LTB4‐synthesizing enzyme system from rat basophilic leukemia (RBL‐1) cells. It was shown that both cyclooxygenase inhibitor indomethacin and adenosine 5′‐triphosphate induced [3H] AA transformation to [3H] LTB4. In optimized conditions up to 15% of total radioactivity of the incubation mixture was present in [3H] LTB4. A separation of [3H] LTB4 from other labelled C20:4 products was achieved by a three‐step reverse phase‐high‐performance liquid chromatography in methanol‐ and acetonitrile‐based solvent systems. [3H] LTB4 was confirmed to be identical to the naturally occurring LTB4 by a radioligand binding assay using a culture of HF1 cells that express a BLT1 receptor. Copyright © 2008 John Wiley & Sons, Ltd. |
| |
Keywords: | [3H] leukotriene B4 enzymatic synthesis rat basophilic leukemia (RBL‐1) cells BLT1 receptor radioligand binding assay |
|
|